Data for ST003364   

(Analysis AN005513): Average values per metabolite and experimental factor (Units:pmol/mg wet tissue weight)

Metabolite structureAll dataF1F2F3F4F5F6F7F8F9F10F11F12F13F14F15F16F17F18F19F20F21F22F23F24F25F26F27F28F29F30F31F32F33F34F35F36F37F38F39F40F41F42F43F44F45F46F47F48F49F50F51F52F53F54F55F56F57F58F59F60F61F62F63F64F65F66F67F68F69F70F71F72F73F74F75F76F77F78F79F80F81F82F83F84F85F86
CL 70:7
0.14 0.15 0.36 0.09 0.22 0.13 0.18 0.13 0.15 0.10 0.11 0.27 0.11 0.13 0.12 0.11 0.11 0.14 0.18 0.12 0.13 0.16 0.08 0.14 0.12
CL 72:6
0.27 0.34 0.58 0.28 1.01 0.21 0.39 0.33 0.48 0.20 0.28 0.64 0.28 0.40 0.38 0.32 0.35 0.41 0.41 0.33 0.36 0.47 0.22 0.42 0.39
CL 72:7
0.58 0.76 1.24 0.65 1.61 0.41 0.86 0.67 0.76 0.36 0.59 1.36 0.48 0.82 0.71 0.61 0.67 0.73 0.77 0.66 0.70 0.86 0.47 0.83 0.84
CL 72:8
0.97 1.06 1.77 0.94 1.77 0.58 1.35 0.96 0.89 0.62 0.87 2.25 0.66 1.01 1.00 0.76 0.79 0.96 0.89 0.83 0.91 1.03 0.69 1.07 0.99
CL 74:10
0.18 0.21 0.42 0.18 0.43 0.12 0.24 0.21 0.18 0.12 0.19 0.48 0.13 0.21 0.22 0.14 0.17 0.20 0.16 0.14 0.17 0.22 0.13 0.21 0.19
GM3 18:1;O2/16:0
1.53 2.04 2.06 4.38 2.35 1.03 1.65 2.02 0.94 1.25 1.42 2.64 1.32 1.45 0.70 1.09 1.80 0.62 2.03 1.83 2.20 0.76 1.59 1.65 0.87
GM3 18:1;O2/18:0
0.57 0.66 0.89 2.34 0.90 0.36 0.50 0.76 0.36 0.47 0.63 1.01 0.65 0.89 0.45 0.47 1.02 0.33 0.90 0.73 1.04 0.41 0.80 0.89 0.54
GM3 34:0;O2
0.06 0.09 0.10 0.15 0.14 0.05 0.07 0.07 0.04 0.05 0.05 0.10 0.08 0.05 0.03 0.04 0.08 0.03 0.08 0.08 0.09 0.03 0.09 0.07 0.04
GM3 34:2;O2
0.10 0.11 0.12 0.39 0.13 0.06 0.10 0.13 0.06 0.09 0.08 0.15 0.07 0.08 0.03 0.06 0.08 0.02 0.11 0.11 0.11 0.03 0.09 0.08 0.04
GM3 36:0;O2
0.02 0.03 0.04 0.04 0.02 0.01 0.02 0.02 0.02 0.01 0.01 0.03 0.03 0.03 0.02 0.02 0.03 0.01 0.03 0.02 0.04 0.02 0.03 0.04 0.02
GM3 36:2;O2
0.11 0.12 0.12 0.61 0.09 0.09 0.12 0.15 0.07 0.11 0.12 0.17 0.12 0.12 0.07 0.08 0.14 0.03 0.16 0.14 0.17 0.05 0.12 0.13 0.08
GM3 38:1;O2
0.17 0.17 0.34 0.45 0.31 0.10 0.19 0.17 0.14 0.16 0.15 0.35 0.31 0.26 0.15 0.18 0.31 0.16 0.25 0.31 0.31 0.17 0.25 0.22 0.16
GM3 38:2;O2
0.06 0.05 0.10 0.13 0.09 0.04 0.06 0.06 0.03 0.04 0.05 0.08 0.07 0.08 0.05 0.07 0.09 0.03 0.09 0.08 0.09 0.04 0.07 0.07 0.05
GM3 39:1;O2
0.07 0.06 0.13 0.19 0.11 0.04 0.05 0.06 0.03 0.06 0.06 0.13 0.11 0.10 0.03 0.07 0.09 0.03 0.08 0.13 0.12 0.07 0.09 0.07 0.04
GM3 40:0;O2
0.05 0.04 0.08 0.04 - 0.02 0.04 0.03 0.02 0.03 0.03 0.10 0.10 0.07 0.05 0.09 0.10 0.07 0.06 0.10 0.07 0.06 0.09 0.05 0.05
GM3 40:1;O2
0.50 0.46 0.99 1.01 1.56 0.34 0.57 0.40 0.28 0.42 0.37 0.96 1.23 0.84 0.55 0.80 1.24 0.73 0.76 0.94 0.82 0.61 0.96 0.63 0.46
GM3 40:2;O2
0.19 0.13 0.22 0.42 0.39 0.13 0.19 0.15 0.10 0.16 0.12 0.25 0.31 0.24 0.12 0.22 0.29 0.15 0.25 0.35 0.28 0.16 0.29 0.19 0.16
GM3 41:1;O2
0.32 0.27 0.42 0.68 0.52 0.23 0.28 0.27 0.15 0.26 0.25 0.58 0.64 0.47 0.27 0.41 0.57 0.30 0.49 0.54 0.52 0.31 0.51 0.37 0.27
GM3 42:1;O2
2.14 2.30 2.03 3.14 3.42 1.32 2.00 1.41 0.74 1.34 1.10 2.79 3.44 2.60 1.79 2.28 4.64 2.53 2.63 3.22 3.19 1.69 2.99 2.31 1.36
GM3 42:2;O2
1.99 1.84 2.25 3.28 3.33 1.27 1.84 1.32 0.79 1.30 1.07 2.53 2.86 1.97 1.47 2.34 3.16 2.39 2.58 2.85 2.78 1.48 2.68 2.12 1.27
GM3 44:1;O2
0.06 0.07 0.07 0.07 0.09 0.03 0.05 0.03 0.02 0.02 0.03 0.07 0.08 0.07 0.06 0.05 0.14 0.06 0.05 0.08 0.09 0.06 0.07 0.06 0.04
GM3 44:2;O2
0.08 0.10 0.08 0.14 0.23 0.05 0.08 0.06 0.04 0.05 0.04 0.12 0.12 0.09 0.08 0.07 0.16 0.10 0.08 0.10 0.12 0.08 0.09 0.09 0.06
LPA 16:0
0.95 0.36 1.52 1.70 0.45 0.59 1.46 0.32 0.24 1.66 0.59 1.39 - - - - - - - - - - - - -
LPA 18:0
1.37 0.56 1.09 3.77 0.50 0.93 5.17 0.35 0.23 4.27 0.71 1.29 - - - - - - - - - - - - -
LPA 18:1
0.71 0.26 0.96 1.05 0.34 0.49 2.61 0.21 0.12 1.07 0.41 0.72 - - - - - - - - - - - - -
LPA 20:4
0.53 0.47 2.43 1.07 0.45 0.48 0.82 0.35 0.35 0.93 0.40 1.54 - - - - - - - - - - - - -
LPI 18:0
0.13 0.91 1.11 3.32 1.00 0.12 0.13 0.69 0.48 0.10 0.36 1.47 0.15 0.26 0.07 0.17 0.16 0.08 0.12 0.19 0.16 0.10 0.16 0.11 0.06
LPI 18:1
0.02 0.12 0.24 0.25 0.11 0.02 0.02 0.10 0.08 0.01 0.06 0.23 0.01 0.02 0.00 0.02 0.01 0.01 0.01 0.02 0.02 0.01 0.01 0.01 0.01
LPI 20:4
0.02 0.12 0.35 0.13 0.08 0.02 0.02 0.13 0.10 0.01 0.07 0.29 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.01 0.01
LPS 18:0
0.19 0.77 0.66 5.51 0.76 0.24 0.21 0.37 0.22 0.23 0.25 1.03 0.04 0.08 0.04 0.06 0.07 0.06 0.03 0.06 0.05 0.05 0.05 0.05 0.04
LPS 18:1
0.20 0.61 1.58 0.58 0.33 0.16 0.17 0.62 0.86 0.07 0.43 1.42 0.01 0.03 0.02 0.01 0.02 0.02 0.01 0.01 0.02 0.03 0.01 0.02 0.02
LPS 20:4
0.04 0.15 0.17 0.26 0.10 0.05 0.03 0.10 0.08 0.02 0.07 0.20 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PA 16:0_18:1
0.77 1.14 1.07 2.45 - 0.70 2.33 0.77 0.76 1.14 0.43 1.55 - - - - - - - - - - - - -
PG 16:0_18:1
0.36 0.40 0.46 0.33 0.54 0.27 0.53 0.47 0.57 0.24 0.36 0.72 0.44 0.73 0.58 0.55 0.56 0.63 0.72 0.64 0.72 0.84 0.65 0.65 0.58
PG 18:1_18:1
1.26 1.05 1.18 0.77 0.71 0.82 2.00 0.86 0.65 0.54 0.47 0.99 1.72 1.04 0.79 1.35 0.98 1.14 1.56 1.35 1.44 0.97 1.24 1.08 0.96
PG 18:1_20:4
0.31 0.44 0.33 0.21 0.17 0.35 0.51 0.21 0.15 0.14 0.14 0.30 0.36 0.29 0.27 0.32 0.30 0.34 0.48 0.29 0.38 0.27 0.29 0.32 0.27
PG 18:1_22:4
0.13 0.15 0.14 0.06 0.12 0.13 0.21 0.09 0.09 0.07 0.08 0.15 0.17 0.15 0.14 0.14 0.16 0.17 0.20 0.13 0.18 0.15 0.14 0.15 0.14
PG 18:1_22:5
0.20 0.25 0.22 0.14 0.18 0.23 0.33 0.16 0.11 0.10 0.11 0.26 0.26 0.25 0.21 0.21 0.24 0.27 0.27 0.23 0.29 0.25 0.22 0.21 0.19
PG 18:1_22:6
0.45 0.47 0.37 0.44 0.36 0.33 0.79 0.31 0.17 0.16 0.19 0.44 0.45 0.37 0.27 0.30 0.32 0.24 0.35 0.51 0.51 0.29 0.45 0.35 0.25
PG 18:2_22:6
0.32 0.32 0.23 0.39 0.22 0.18 0.51 0.21 0.09 0.11 0.10 0.29 0.27 0.23 0.16 0.15 0.19 0.13 0.17 0.28 0.30 0.14 0.25 0.20 0.14
PG 20:4_20:4
0.05 0.09 0.05 0.05 0.03 0.07 0.07 0.04 0.02 0.02 0.03 0.06 0.05 0.05 0.04 0.05 0.05 0.05 0.07 0.04 0.06 0.04 0.05 0.05 0.04
PI 16:0_16:0
0.25 0.31 0.33 0.38 0.40 0.27 0.20 0.23 0.18 0.18 0.25 0.38 0.25 0.54 0.23 0.31 0.39 0.23 0.37 0.47 0.53 0.28 0.32 0.32 0.22
PI 16:0_16:1
0.35 0.34 0.29 0.25 0.13 0.24 0.24 0.27 0.15 0.31 0.29 0.35 0.29 0.41 0.15 0.25 0.26 0.18 0.60 0.49 0.56 0.22 0.26 0.26 0.18
PI 16:0_18:1
2.49 2.64 2.76 3.43 2.73 1.84 2.04 2.58 1.87 2.01 2.35 3.36 2.63 4.21 2.32 2.85 3.37 2.57 4.17 3.87 4.46 2.90 2.69 3.05 2.34
PI 16:0_18:2
0.91 0.93 1.21 1.08 0.81 0.55 0.90 0.91 0.63 0.73 0.91 1.31 0.94 1.40 0.80 1.00 1.02 0.72 1.43 1.37 1.52 0.87 0.95 1.03 0.84
PI 16:0_20:4
3.10 3.24 3.04 3.01 2.21 2.13 3.36 3.53 2.61 2.18 2.58 4.33 2.76 4.48 2.88 3.04 3.60 3.36 5.44 4.45 5.01 3.78 3.44 3.85 3.12
PI 16:0_22:6
0.20 0.18 0.14 0.26 0.11 0.13 0.20 0.21 0.12 0.14 0.17 0.21 0.16 0.23 0.12 0.18 0.15 0.10 0.30 0.30 0.27 0.15 0.19 0.19 0.13
PI 17:0_18:2
0.07 0.08 0.08 0.12 0.07 0.06 0.08 0.07 0.03 0.05 0.07 0.09 0.07 0.10 0.05 0.06 0.06 0.05 0.10 0.12 0.12 0.05 0.07 0.09 0.06
PI 17:0_20:4
0.36 0.41 0.36 0.45 0.43 0.33 0.41 0.39 0.25 0.29 0.33 0.55 0.42 0.58 0.34 0.40 0.46 0.39 0.54 0.63 0.59 0.51 0.45 0.47 0.36
PI 18:0_18:1
2.10 2.27 2.41 3.91 3.36 1.55 2.23 2.33 1.51 1.85 1.98 2.81 2.91 4.16 2.42 3.09 3.76 2.80 4.16 4.18 4.39 2.87 3.01 3.40 2.49
PI 18:0_20:3
1.04 0.89 1.03 1.15 1.28 0.85 1.31 1.00 0.83 0.87 0.92 1.57 1.24 1.74 1.17 1.28 1.23 1.02 1.35 1.68 1.59 1.32 1.30 1.18 1.04
PI 18:0_20:4
35.96 33.13 42.09 37.76 37.45 26.35 41.28 35.87 28.14 27.13 29.98 48.57 40.04 51.14 35.77 40.12 45.65 40.52 55.79 55.38 54.99 46.30 48.04 46.40 38.08
PI 18:0_22:4
0.38 0.41 0.36 0.47 1.02 0.42 0.54 0.38 0.33 0.31 0.37 0.79 0.64 0.77 0.50 0.64 0.72 0.70 0.80 0.78 0.69 0.71 0.72 0.62 0.51
PI 18:0_22:5
0.70 0.54 0.67 1.09 1.37 0.53 0.74 0.56 0.43 0.55 0.55 0.75 0.75 0.92 0.57 0.83 0.70 0.61 0.99 1.10 1.05 0.81 0.88 0.75 0.61
PI 18:0_22:6
0.47 0.46 0.47 0.74 0.56 0.34 0.50 0.49 0.30 0.36 0.42 0.63 0.50 0.66 0.30 0.57 0.52 0.30 0.74 0.85 0.74 0.46 0.66 0.60 0.45
PI 18:1_18:1
1.32 1.36 1.91 1.56 1.55 1.02 1.46 1.21 1.09 0.91 1.06 1.68 1.30 2.00 1.39 1.54 1.68 1.63 2.43 1.79 2.09 1.61 1.46 1.67 1.36
PI 18:1_20:4
3.56 3.73 4.07 2.92 3.79 3.09 4.42 3.54 2.98 2.50 3.02 4.91 3.19 4.87 3.47 3.52 4.21 4.25 5.92 4.95 4.83 4.15 3.93 4.21 3.31
PI 20:4_20:4
0.04 0.04 0.03 0.05 0.01 0.03 0.07 0.05 0.03 0.03 0.03 0.07 0.03 0.06 0.04 0.04 0.06 0.08 0.10 0.04 0.05 0.03 0.05 0.05 0.04
PS 16:0_18:0
0.50 1.11 0.85 1.08 1.04 0.70 0.95 0.87 0.40 0.49 0.60 1.03 0.39 0.75 0.58 0.61 0.63 0.71 0.90 0.46 0.78 0.47 0.47 0.82 0.46
PS 16:0_18:1
0.91 1.37 2.63 0.81 1.59 0.92 1.22 1.15 1.03 0.70 0.94 1.98 0.53 1.16 1.25 0.89 0.97 1.92 1.49 0.83 1.07 1.53 0.83 1.18 1.08
PS 18:0_18:1
52.91 100.76 131.38 46.88 45.17 39.37 79.49 115.17 70.29 35.66 73.88 137.76 29.90 93.80 84.13 38.00 81.04 90.03 81.26 49.97 89.89 85.82 37.27 89.71 73.12
PS 18:0_18:2
2.00 2.82 4.58 3.11 5.70 1.57 2.95 2.23 2.10 1.34 1.89 4.72 1.39 2.43 3.02 1.87 2.01 3.03 2.23 1.88 2.42 2.93 1.76 2.60 2.09
PS 18:0_20:3
4.37 5.94 10.56 3.42 8.57 4.90 5.83 6.13 6.11 3.62 5.12 13.19 3.66 6.94 7.83 4.13 5.64 7.10 5.30 4.88 6.03 7.74 3.89 5.62 5.58
PS 18:0_20:4
4.62 8.86 9.05 8.38 19.34 5.50 6.25 6.31 6.08 4.06 6.02 14.98 4.60 8.75 8.12 6.58 6.78 11.12 6.89 5.11 6.17 8.94 4.72 7.12 6.98
PS 18:0_22:4
6.13 10.42 9.57 7.12 12.76 6.85 9.07 9.52 5.72 5.30 8.51 15.72 5.48 13.12 9.90 7.31 10.51 11.15 10.88 7.37 9.36 9.90 6.03 11.09 9.56
PS 18:0_22:5
4.00 5.89 9.09 4.95 9.79 4.42 4.83 5.52 4.86 3.12 5.68 11.05 3.31 7.64 6.97 4.67 6.08 9.18 6.29 4.86 6.09 8.22 3.84 6.13 5.95
PS 18:0_22:6
7.47 9.46 14.01 9.68 13.84 6.06 9.06 10.22 7.85 4.38 8.72 17.58 4.37 10.69 8.67 6.07 7.13 9.55 8.57 7.15 9.04 10.82 5.62 9.09 8.66
PS 18:1_20:1
1.39 2.45 5.74 0.89 1.10 0.78 1.86 2.48 2.36 0.87 1.81 3.80 0.93 2.40 2.80 1.02 2.01 3.04 2.38 1.36 2.76 3.37 1.04 2.74 2.57
PS 18:1_22:1
0.80 1.18 3.24 0.41 1.31 0.50 1.01 1.21 1.71 0.49 1.16 2.71 0.61 1.43 2.01 0.82 1.28 1.87 1.25 0.82 1.54 1.86 0.67 1.54 1.63

Factors:

F1Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed
F2Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed
F3Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F4Analysis method:Folch extraction and untargeted MS10 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F5Analysis method:Folch extraction and untargeted MS11 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F6Analysis method:Folch extraction and untargeted MS12 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F7Analysis method:Folch extraction and untargeted MS13 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F8Analysis method:Folch extraction and untargeted MS14 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F9Analysis method:Folch extraction and untargeted MS15 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F10Analysis method:Folch extraction and untargeted MS16 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F11Analysis method:Folch extraction and untargeted MS17 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F12Analysis method:Folch extraction and untargeted MS18 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F13Analysis method:Folch extraction and untargeted MS19 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F14Analysis method:Folch extraction and untargeted MS1 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F15Analysis method:Folch extraction and untargeted MS20 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F16Analysis method:Folch extraction and untargeted MS21 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F17Analysis method:Folch extraction and untargeted MS22 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F18Analysis method:Folch extraction and untargeted MS23 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F19Analysis method:Folch extraction and untargeted MS24 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F20Analysis method:Folch extraction and untargeted MS25 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F21Analysis method:Folch extraction and untargeted MS26 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F22Analysis method:Folch extraction and untargeted MS27 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F23Analysis method:Folch extraction and untargeted MS28 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F24Analysis method:Folch extraction and untargeted MS29 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F25Analysis method:Folch extraction and untargeted MS2 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F26Analysis method:Folch extraction and untargeted MS30 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F27Analysis method:Folch extraction and untargeted MS31 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F28Analysis method:Folch extraction and untargeted MS32 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F29Analysis method:Folch extraction and untargeted MS33 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F30Analysis method:Folch extraction and untargeted MS34 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F31Analysis method:Folch extraction and untargeted MS35 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F32Analysis method:Folch extraction and untargeted MS36 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F33Analysis method:Folch extraction and untargeted MS37 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F34Analysis method:Folch extraction and untargeted MS38 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F35Analysis method:Folch extraction and untargeted MS39 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F36Analysis method:Folch extraction and untargeted MS3 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F37Analysis method:Folch extraction and untargeted MS40 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F38Analysis method:Folch extraction and untargeted MS41 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F39Analysis method:Folch extraction and untargeted MS42 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F40Analysis method:Folch extraction and untargeted MS43 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F41Analysis method:Folch extraction and untargeted MS44 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F42Analysis method:Folch extraction and untargeted MS4 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F43Analysis method:Folch extraction and untargeted MS5 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F44Analysis method:Folch extraction and untargeted MS6 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F45Analysis method:Folch extraction and untargeted MS7 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F46Analysis method:Folch extraction and untargeted MS8 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F47Analysis method:Folch extraction and untargeted MS9 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F48Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:calcific
F49Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:fibrotic
F50Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:mildly diseased
F51Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:male | Pathology:fibrotic
F52Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:male | Pathology:mildly diseased
F53Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed
F54Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:calcific
F55Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:fibrotic
F56Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:mildly diseased
F57Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:calcific
F58Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:fibrotic
F59Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:mildly diseased
F60Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:calcific
F61Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic
F62Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:mildly diseased
F63Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific
F64Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic
F65Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:mildly diseased
F66Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F67Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific
F68Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic
F69Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:mildly diseased
F70Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific
F71Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic
F72Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased
F73Analysis method:Untargeted lipidomics for human AV lipids identification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F74Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:calcific
F75Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic
F76Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:mildly diseased
F77Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific
F78Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic
F79Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:mildly diseased
F80Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
F81Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific
F82Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic
F83Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:mildly diseased
F84Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific
F85Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic
F86Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased
  logo